CLL Treatment: More Diseases in Real Patients

Published Date: 13 Mar 2023

Severe disease has been observed in patients with chronic lymphocytic leukemia (CLL) or B-cell lymphoma who took ibrutinib (Imbruvica), idelarisib (Zydelig), or venetoclax (Venclexta).

Read Full News

Latest News

The next great performance booster for athletes? Sleep

When we think of elite athletes, we generally think of people who are at the top of their game physically.

Ablation reduces stroke risk for atrial fibrillation and may remove need for some types of blood thinners

A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of stroke enough that some patients can discontinue blood thinners, according to a preliminary late-breaking ...

Earlier blood transfusion may reduce heart failure, arrhythmia in adults with heart disease

An earlier blood transfusion—done when hemoglobin levels were higher—after major general or vascular surgery among people with heart disease was associated with a lower risk of some complications but not the most severe ...

Preparing for a tough exam? A tough gym workout could help with your studies

A new study by researchers at Coventry University has found a high-intensity gym workout appears to increase your ability to focus, remember and process information in your brain.

Frankenstein: Could an assembled body ever breathe, bleed or think? Anatomists explain

Frankenstein's creature is coming back to life—again. As Guillermo del Toro's new adaptation of Mary Shelley's gothic masterpiece airs on Netflix, we provide an anatomist's perspective of her tale of reanimation. Could ...

Biomaterial vaccines could make implanted orthopedic devices safer

Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a small but significant risk that these devices get infected with bacterial pathogens. This starts them ...

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Todays Updates

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Enhancing Comprehensive Biomarker Testing and Biomarker-Directed Treatment Selection

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Advancing Care in ES-SCLC: Personalized Strategies, New Therapies, and Real-World Insights

Adjuvant Combination for Kidney Cancer Gets FDA's Blessing

Belzutifan and pembrolizumab together reduced the risk of disease recurrence or death

FDA Approves Prostate Cancer Combo That Warranted Advisory Meeting

Capivasertib plus abiraterone combination lands indication for PTEN-deficient tumors

Talquetamab Regimens Boost Survival in Multiple Myeloma

"Combinations represent additional options for early-line treatment," researcher says

In High-Risk B-Cell ALL, Swapping Out Chemo for Blinatumomab Improves Outcomes

The bispecific T-cell engager also reduced toxicity in newly diagnosed kids

Timely 'Nudges' Can Help Encourage More End-of-Life Conversations in Cancer

A combination of clinician and patient prompts worked best, but talks remained infrequent

Latest News

When we think of elite athletes, we generally think of people who are at the top of their game physically.

A minimally invasive heart procedure to correct irregular heart rhythms called catheter ablation may reduce the risk of stroke enough that some patients can discontinue blood thinners, according to a preliminary late-breaking ...

An earlier blood transfusion—done when hemoglobin levels were higher—after major general or vascular surgery among people with heart disease was associated with a lower risk of some complications but not the most severe ...

A new study by researchers at Coventry University has found a high-intensity gym workout appears to increase your ability to focus, remember and process information in your brain.

Frankenstein's creature is coming back to life—again. As Guillermo del Toro's new adaptation of Mary Shelley's gothic masterpiece airs on Netflix, we provide an anatomist's perspective of her tale of reanimation. Could ...

Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a small but significant risk that these devices get infected with bacterial pathogens. This starts them ...

News All Time

How's your hydration? A new tool from researchers helps athletes find out

Researchers at the Korey Stringer Institute (KSI) in the College of Agriculture, Health and Natural Resources (CAHNR) have created an open-access document to help athletes, coaches, and parents understand the latest research ...

From monkey glands to 'young blood': The long, strange history of chasing immortality through transplants

When Russian president Vladimir Putin visited Beijing in September 2025, he told Chinese leader Xi Jinping that repeated organ transplants might make a person "get younger" and even live to 150. The remark was widely dismissed ...

Sentinel lymph node biopsy noninferior to lymphadenectomy in cervical cancer

For patients with early-stage cervical cancer, sentinel lymph node biopsy alone is noninferior to lymphadenectomy with respect to disease-free survival, according to a study published online Oct. 15 in the New England Journal ...

Gender equality universally linked to physical capacity

Fitness among young adults varies widely from one country to another, and is strongly associated with both socioeconomic development and gender equality, a new study from Karolinska Institutet published in the Journal of ...

Abnormal cell 'conversations' drive chronic lung-transplant rejection, research reveals

More than 50% of lung-transplant recipients experience a rejection of their new lung within five years of receiving it, yet the reason why this is such a prevalent complication has remained a medical mystery.

Fewer women receive lung transplants despite policy changes, study finds

New research from UCLA Health reveals that women continue to face barriers in accessing lung transplants compared to men, despite recent national policy changes aimed at making organ distribution more equitable.

How is radiation therapy portrayed in art?

Because patient perceptions of radiation can influence their willingness to receive it as treatment, researchers recently examined how radiation therapy is represented in different forms of art.

Infrared sauna may hold benefits for team-sport athletes

A study conducted by the Faculty of Sport and Health Sciences at the University of Jyväskylä, Finland, suggests that using an infrared sauna after exercise can speed up recovery and support performance in team-sport athletes. ...

LeBron James will be the first NBA player to reach 23 seasons. How is he still one of the best?

A common saying in sport is: "Father Time is undefeated."

Physical activity raises daily calorie burn without conserving energy used elsewhere, study finds

The effects of physical activity don't stop when the movement does. In a new study published in the Proceedings of the National Academy of Sciences, Virginia Tech researchers, in collaboration with researchers at the University ...

Rising demands, rising performance: Australian Football League Women's players push limits in finals season

As the Australian Football League Women's (AFLW) finals edge closer, players across the league are preparing to push their limits. Now, new research from the University of South Australia shows that AFLW players are pushing ...

Minimally invasive surgery may improve outcomes in severe stroke

Minimally invasive endoscopic surgery may be an effective and safe treatment for patients with intracerebral hemorrhage, the most severe type of stroke, according to results from a recent clinical trial published in JAMA ...

Could your walk be a signal about your ability to win a fight?

Humans have been fighting each other since the earliest stages of our species' history.

Built-in backup system helps muscles counteract fatigue

When you're running up stairs or out on a jog, your muscles eventually start to feel heavy and weak. That's fatigue setting in, a sign that the muscles' energy reserves are becoming depleted. But a team of researchers led ...

GPS technology reveals that football practices can be up to 40% more demanding than games

Until recently, there has been little data available on how much effort football players exert in games versus practices, which position groups run the most or how to balance loads in practice to best meet the needs of game ...

The exercise paradox: Why workouts aren't great for weight loss but useful for maintaining a healthy body weight

The basic principle of weight loss is straightforward: if you consume fewer calories than you burn, you'll lose weight. In practice though, this isn't usually so easy or simple.

Recommended News For You

According to JAMA, 5 alpha-reductase inhibitors are not significantly linked to prostate cancer mortality.

FDA OKs Subcutaneous Daratumumab Plus VRd for Myeloma

Smart exercise planning could boost recovery for people with cancer

Alternative Medicine for Breast Cancer: Study Raises Concern

Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

Report: High risk of lung cancer from respirable crystalline silica even below the current occupational exposure limit

Patients with head and neck cancer who cannot receive cisplatin now have new hope.

Recommended Articles For You

Clinical Methods in Hematology and Quality Improvement 

Using Node Technology to Fight Breast Cancer: A New Hope for Early Detection 

Gene Therapy for Hemophilia: A New Hope on the Horizon 

Unexplained Weight Loss: Revealing Occult Cancers and Paraneoplastic Syndromes 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Inner Thoughts of Leonard Bernstein, the "Maestro".

2.

Mobile prostate cancer screening clinic can ID the disease in disadvantaged men

3.

No Survival Benefit Seen With Adjuvant Atezolizumab in TNBC

4.

Parents, teachers at Missouri school want answers after string of cancer diagnoses

5.

A promising medication could slow brain tumors in children.

1.

Future-Ready Cancer Screening: What Every Clinician Should Know in 2025

2.

Cancer Evolution and Therapeutic Resistance: Mechanisms, Clinical Insights, and Emerging Strategies

3.

Targeting Cancer Stem Cells in Solid Tumors: Mechanisms, Clinical Implications, and Therapeutic Advances

4.

Partial Gland Ablation in Prostate Cancer: Oncologic Outcomes in Intermediate-Risk Cases

5.

Generative AI for Adaptive Oncology Trial Design

1.

Asian Symposium on Advancement in Hematology and Oncology

2.

Asian Symposium on Advancement in Hematology and Oncology

3.

Asian Symposium on Advancement in Hematology and Oncology

4.

International Cancer Conference

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Management of 1st line ALK+ mNSCLC (CROWN TRIAL Update) - Part III

2.

Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I

3.

Recent Data Analysis for First-Line Treatment of ALK+ NSCLC

4.

INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients

5.

Current Scenario of Cancer- The Incidence of Cancer in Men

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot